The goal of the Health Product InfoWatch is to raise awareness and to provide clinically relevant information to healthcare professionals concerning marketed health products and their safety. In some cases, information is intended to stimulate reporting of similar adverse reactions. Each publication includes a monthly recap of health product advisories and summary safety reviews, as well as a growing selection of new health product safety information.
Prescribing must comply with standards
April 15, 2025
Only pharmacists with additional prescribing authorization may prescribe Schedule 1 drugs to initiate therapy, unless in an emergency.
Read more ➞
